Simple research view

PFE · Pfizer, Inc.

$27.65 -0.47% Sep 10 close

Detected setup watchlist_candidate · Setup Score 0/100

Stand aside — setup invalidated

Setup score 0, but distribution days reach 5 or more — stand aside until the condition resets.

Ask about PFE

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

$PFE

Pfizer, Inc.

Pfizer, Inc. is a large-cap Pharmaceuticals: Major company in the Health Technology sector with a market cap of $158B.

Health Technology Pharmaceuticals: Major stock Stage 2 · Advancing Base 2

$27.65 latest close

Join to Watchlist $PFE Share card

Verdict · setup score 0/100 · data Sep 10 close · 1 session old

Stand aside — setup invalidated

Setup score 0, but distribution days reach 5 or more — stand aside until the condition resets.

Review six verdicts Inspect chart

Earnings

Normal technical setup

No sourced report date Event risk is not modelled for this symbol

Deterministic evidence

PFE-0.47%

Broad market · SPY-0.60%

Same completed session window ending 2026-09-10. +0.13 points vs SPY.

Session internals Mixed

Rule: direction and internals disagree — it met neither the strong nor the weak rule. Judged on internals, not on the size of the move.

Vs prior close-0.47% From the open-0.29% Range position71% GapNo gap

QQQ confirmationConfirming (-1.06%) SMH confirmationConfirming (-2.44%)

Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

Ask a Legend to interpret this evidence → Commentary only — never scanner evidence or a sizing recommendation.

Price $27.65 -0.5% Sep 10 close

52W High $29.21 5.3% below high

Wks Since High 1w 0w today

Base Depth 4.7% 6.2% today

RS Rank 11 percentile of scan

SMA 50 $26.19

Avg Vol 38,390,728

Rel Vol (Sep 10) 0.75×

More stats

52W Low $23.58

Tight Wks 0

Base B2

SMA 200 $26.21

RS Line vs High -17.0%

RS Line Slope +5.9% ▲

Group Rank #27/58

ADR% 1.8%

ATR(14) $0.57 (2.0%)

Vol Pace (live) N/A

U/D Vol 1.46

A/D Days 21A / 12D

A/D Rating A+

VDU Bars 0/10 d

Position in 52-week range 72ndpercentile of the 52-week range

$23.58low

$29.21high

PFE Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for PFE.

Create Free Account

Technical Analysis Report Card

$PFE · $27.65 · as of 2026-09-10 · multi-factor read

/ 100

Technicals 58/100

Reference read from price & volume only — the verdict at the top of the page decides the action.

Trend · Daily / Weekly / Monthly

Daily ▬ Sideways / consolidating

Weekly ▲ Uptrend

Monthly ▲ Uptrend

Moving Averages

50-day$26.19 ↑

100-day$26.02 ↑

200-day$26.21 ↑

Bearish (50 < 200)

RSI (14)

Reading52.1 · Neutral

Neutral — momentum is balanced between buyers and sellers.

MACD (12/26/9)

StateWeakening

Histogram-0.162

Weakening — MACD slipped below its signal line. Histogram contracting.

Bollinger Bands (20,2)

%B / Width38% · 9.2%

Mid-band — no directional band edge in play.

Volume · Buyer vs Seller

Up/Down vol1.46 · Neutral

Rel volume0.75×

Balanced — up/down volume is roughly even; no clear hand. Recent volume is easing versus its baseline.

Support & Resistance

R · $27.86swing level

R · $28.75swing level

R · $29.2152-week high

Price · $27.65now

S · $26.68swing level

S · $26.36swing level

S · $25.23swing level

Fibonacci · Uptrend swing

23.6% ◄ price here$27.89

38.2%$27.07

50.0%$26.41

61.8%$25.76

78.6%$24.82

Retracement support zones measured from the recent swing low up to the high.

The verdict is free. The trade plan is Pro.

Unlock the exact entry, stop-loss, profit target, and reward-to-risk for PFE — plus the full 500+ symbol scanner and Ask-the-Legends chat.

Start your 7-day free trial →

Weekly uptrendMonthly uptrendAbove 200-day MA50/200 bearishRS 17 (laggard)

Want this read in a legend's voice? Ask a Legend about PFE

Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →

Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.

Council consensus: 4 of 6 legends are Watching — building, not yet a confirmed buy.

Minervini

Avoid

Minervini C

Trend-template read: fails 50-day MA > 150-day MA AND 200-day MA.

Passing evidence

1.1 Price > 150-day MA AND 200-day MAPrice $27.65, MA150 $26.42, MA200 $26.21

1.2 150-day MA > 200-day MAMA150 $26.42 vs MA200 $26.21

Failing evidence

1.4 50-day MA > 150-day MA AND 200-day MAMA50 $26.19, MA150 $26.42, MA200 $26.21

1.8 RS rank ≥ 70 (prefer ≥ 85)RS rank 17

5/8 checks

Method → Playbook → Ask →

O'Neil

Avoid

O'Neil D

CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.

Passing evidence

N: Near 52-week high or RS line new high5.3% below high | RS line new high: False

S: Base tightness (ATR% ≤ 4.5%)ATR% 2.05%

Failing evidence

L: RS rank ≥ 80 (IBD leadership)RS rank 17

C: Quarterly EPS acceleration ≥ 25%Data unavailable

2/8 checks

Method → Playbook → Ask →

Weinstein

Watch

Weinstein D

Stage-analysis read: Stage 2 is present; 3 supporting checks need improvement.

Passing evidence

Stage 2 (Advancing phase) confirmedStage 2 (Advancing)

Price above 30-week MA (200-day proxy)Price $27.65 vs MA200 $26.21

Failing evidence

Volume expansion above averageVolume ratio 0.75x

Relative strength ≥ 60RS 17

3/6 checks

Method → Playbook → Ask →

Livermore

Watch

Livermore B

Pivotal-point read: constructive evidence is present, but relative strength is unresolved.

Passing evidence

Price$27.65

Distance from 52-week high5.3% below high

Failing evidence

Relative strengthRS 17

Volume vs average0.75x

3/6 checks

Method → Playbook → Ask →

Darvas

Watch

Darvas B

Box-theory read: constructive evidence is present, but relative strength is unresolved.

Passing evidence

Price$27.65

Distance from 52-week high5.3% below high

Failing evidence

Relative strengthRS 17

Volume vs average0.75x

3/6 checks

Method → Playbook → Ask →

Wyckoff

Watch

Wyckoff B

Supply-and-demand read: constructive evidence is present, but relative strength is unresolved.

Passing evidence

Price$27.65

Distance from 52-week high5.3% below high

Failing evidence

Relative strengthRS 17

Volume vs average0.75x

3/6 checks

Method → Playbook → Ask →

Base & Breakout

Breakout follow-through

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

Latest candle: Hammer — Long lower shadow with a small body near the high — buyers rejected lower prices. Bullish when it appears at support or after a pullback.

Unlock Base & Breakout Tracking

RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH ▲ Rising

Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net +11 A+

Minervini · Grade Card

Fundamentals & leadership quality — Minervini’s published criteria · 2/7 met

C 2/7 criteria

Separate score from the Minervini Trend Template (5/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.

✗ EPS acceleration ≥25% QoQ —

✗ Revenue growth ≥20% YoY -2%

✗ Gross margin ≥30% —

✗ ROE ≥17% —

✗ RS rating ≥80 (leadership) 17

✓ Stage 2 uptrend (Weinstein) Stage 2

✓ Within 25% of 52W high -5.3%

Method Playbook

Trade it like Darvas EXACT LEVELS · PRO

Minervini O'Neil Livermore Weinstein Darvas Wyckoff

Darvas B · Watch — The deterministic methodology check is Watch; wait for the failing or incomplete criteria to improve before the trigger can qualify.

Pivot

Pro level

Published-method rule: Use the top of the active Darvas box near the high as the mechanical breakout boundary.
Evidence: Canonical setup geometry is available with Pro.

Entry trigger

Pro level

Published-method rule: Require price to clear the box top with volume confirmation; movement inside the box remains observation, not a trigger.
Evidence: Canonical setup geometry is available with Pro.

Initial stop

Pro level

Published-method rule: Start below the active box support or the canonical structural stop that proves the breakout failed.
Evidence: Canonical setup geometry is available with Pro.

Trail

Rule-based

Published-method rule: As higher boxes form, raise the stop beneath the newest confirmed box floor; the stop moves up only.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.

Exit / invalidation

Pro level

Published-method rule: Exit when price breaks the active box floor or decisively falls back through the breakout structure.
Evidence: Canonical setup geometry is available with Pro.

Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →

The published-method workflow is public. Unlock exact pivot, entry, stop, target, and sizing with Pro →

Forming Patterns (predictive — not confirmed)

Cup & Handle bullish near confirmation

90% built

Cup complete, possible handle forming — watch for a quiet 5-15 bar drift on light volume holding above ~26.19 (mid-cup), then a breakout through ~29.21 on strong volume.

Confirms above 29.21

Invalidates at 26.19

Rim 28.75

Cup Low 23.62

Pivot 29.21

Mid Cup 26.19

Cup depth 18%, recovery 79%, handle=forming

Predictive pattern recognition is educational — most forming structures never confirm. Wait for the confirmation level before treating this as a setup.

Pattern Analysis

watchlist_candidate

0 setup score

RS Score 17

Trend template 5/8

Why This Setup?

watchlist_candidate · schematic

Near-miss 5/8 — needs: sma50 above sma150 200, price above 30pct of 52w low, rs score above 70

The Universal Edge Check · context only

What the setup still has going for it, recorded for later. The verdict above stands — these principles do not overrule it.

1/7 universals met

A relative-strength leader — not met RS rank 11 — laggard
Risk is defined — not met No stop — undefined risk
Asymmetric reward — partly met No target set
Clear of earnings — partly met Report date unknown
Not chasing (in range) — partly met Pivot distance unknown
Volume confirms — partly met 0.8× average — light
In a confirmed uptrend — met Stage 2 · Trend template 5/8

Why these seven? → The Universal Edge

Minervini Trend Template

5/8

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $27.65 vs SMA150 $26.42 / SMA200 $26.21

SMA 150 above SMA 200 SMA150 $26.42 vs SMA200 $26.21

SMA 200 trending up Slope +0.31 over 20 days

SMA 50 above SMA 150 & 200 SMA50 $26.19

Price above SMA 50 $27.65 vs SMA50 $26.19

30%+ above 52-week low +17.3% from $23.58

Within 25% of 52-week high -5.3% from $29.21

RS score above 70 RS 17

Fundamentals

52W Range

72%

Mkt Cap SEC

157.6B

Rev YoY

-2%

EPS TTM

$1.36

P/E TTM

20.3x

Float

5.7B

Company

Company profile

Pfizer, Inc.

PFE · NYSE · Health Technology · Pharmaceuticals: Major

Get the full picture on PFE

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 500+ symbols daily.

Start 7-Day Free Trial